EPO Patents = 2

Forward Citations = 232

Loading Chart...

4 inventors (with patents filed for the assignee):

Jonathan LeBowitz (5 out of 23 patents)

Stephen M Beverley (4 out of 10 patents)

John Maga (1 out of 4 patents)

4. William S Sly (1 out of 8 patents)

5 patents: Sort by Forward Citations

1. 7858576 - Method for targeting lysosomal enzymes (2010-12-28),

2. 7785856 - Acid alpha-glucosidase and fragments thereof (2010-08-31),

3. 7629309 - Targeted therapeutic proteins (2009-12-08),

4. 7560424 - Targeted therapeutic proteins (2009-07-14),

5. 7396811 - Subcellular targeting of therapeutic proteins (2008-07-08),

Zystor Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for rare genetic disorders. With a strong emphasis on research and development, Zystor Therapeutics is committed to advancing treatment options for patients with unmet medical needs. The company's pipeline includes potential treatments for various lysosomal storage disorders and other rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#142 in Milwaukee, WI

#1,070 in Wisconsin

#50,135 in US

Milwaukee, WI, United States of America

Zystor Therapeutics, Inc.

Forward Citations = 232

4 inventors:

Jonathan LeBowitz (5 out of 23 patents)

Stephen M Beverley (4 out of 10 patents)

John Maga (1 out of 4 patents)

4. William S Sly (1 out of 8 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com